Categorynews

The Worldwide Thyroid Eye Disease Treatments Industry is Projected to Reach $428 Million by 2027 – ResearchAndMarkets.com

July 25, 2022 Off By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Thyroid Eye Disease Treatments Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering.

The Global Thyroid Eye Disease Treatments Market is projected to reach USD 428.35 million by 2027 from USD 249.41 million in 2021, at a CAGR 9.43% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

  • The Americas Thyroid Eye Disease Treatments Market size was estimated at USD 89.71 million in 2021 and expected to reach USD 98.03 million in 2022, at a CAGR 9.43% to reach USD 154.12 million by 2027.
  • The Asia-Pacific Thyroid Eye Disease Treatments Market size was estimated at USD 64.87 million in 2021 and expected to reach USD 72.09 million in 2022, at a CAGR 10.03% to reach USD 115.16 million by 2027.
  • The Europe, Middle East & Africa Thyroid Eye Disease Treatments Market size was estimated at USD 94.83 million in 2021 and expected to reach USD 102.38 million in 2022, at a CAGR 9.00% to reach USD 159.06 million by 2027.

Market Segmentation & Coverage:

This research report categorizes the thyroid eye disease treatments to forecast the revenues and analyze the trends in each of the following sub-markets:

Drug:

  • Corticosteroid
  • Monoclonal Antibody
  • Vitamin

Route of Administration:

  • Oral
  • Topical

Treatment:

  • Medication
  • Radioactive Iodine Therapy
  • Surgery

Diagnosis:

  • Blood Test
  • Imaging Test
  • Physical Exam
  • Radioactive Iodine Uptake Test
  • Orbital Ultrasound

Distribution:

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Region:

  • Americas

    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
  • Asia-Pacific

    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
  • Europe, Middle East & Africa

    • France
    • Germany
    • Italy
    • Netherlands
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • United Arab Emirates
    • United Kingdom

Company Usability Profiles:

  • Abbott Laboratories Inc.
  • AbbVie, Inc.
  • Akron Inc.
  • AMRI Global
  • Bausch & Lomb Incorporated
  • Bayer AG
  • Eyevance Pharmaceuticals LLC
  • Fujifilm Holdings Corporation
  • GlaxoSmithKline PLC
  • Horizon Therapeutics PLC
  • Immunovant, Inc.
  • Kala Pharmaceuticals, Inc.
  • Merck KGaA
  • Pfizer Inc.
  • RLC Labs
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris

For more information about this report visit https://www.researchandmarkets.com/r/wxhovf

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900